Related Experiment Video

Updated: Jun 23, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Tumor metabolic phenotypes on 18F FDG PET

Ching-Yee Oliver Wong, Pek-Lan Khong

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |May 16, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
    07:07

    Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

    Published on: May 2, 2017

    Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
    10:28

    Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

    Published on: January 22, 2018

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
    07:07

    Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

    Published on: May 2, 2017

    Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
    10:28

    Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

    Published on: January 22, 2018

    Related Concept Videos

    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
    Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

    Imaging Studies II: Positron Emission Tomography and Scintigraphy

    Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
    Fundamental Principles of PET

    Articles linked to this work by shared authors, journal, and citation graph.

    Limbic free-water alterations as neuroimaging biomarkers for predicting phenoconversion in prodromal Parkinson's disease.

    Parkinsonism & related disorders·2026

    Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma.

    Clinical nuclear medicine·2025

    Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk.

    European journal of neurology·2025

    Epigenetics in Heart Failure.

    International journal of molecular sciences·2024

    Targeted Radionuclide Therapy in Glioblastoma.

    ACS applied materials & interfaces·2024

    Dual-tracer PET/CT in the management of hepatocellular carcinoma.

    JHEP reports : innovation in hepatology·2024

    Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    68Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Real-World Outcomes of [177Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Concordance Between [18F]Flortaucipir PET Visual Reads and CenTauR-Based Quantification.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us